BR9607796A - Forma sólida de medicamento - Google Patents

Forma sólida de medicamento

Info

Publication number
BR9607796A
BR9607796A BR9607796A BR9607796A BR9607796A BR 9607796 A BR9607796 A BR 9607796A BR 9607796 A BR9607796 A BR 9607796A BR 9607796 A BR9607796 A BR 9607796A BR 9607796 A BR9607796 A BR 9607796A
Authority
BR
Brazil
Prior art keywords
pct
medicine
date sep
solid form
sec
Prior art date
Application number
BR9607796A
Other languages
English (en)
Inventor
Axel Sanner
Joerg Rosenberg
Jens Rieger
Jorg Breteinbach
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of BR9607796A publication Critical patent/BR9607796A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
BR9607796A 1995-03-21 1996-03-09 Forma sólida de medicamento BR9607796A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19509806A DE19509806A1 (de) 1995-03-21 1995-03-21 Lagerstabile Arzneiformen
PCT/EP1996/001019 WO1996029060A1 (de) 1995-03-21 1996-03-09 Lagerstabile arzneiformen

Publications (1)

Publication Number Publication Date
BR9607796A true BR9607796A (pt) 1998-07-07

Family

ID=7757017

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9607796A BR9607796A (pt) 1995-03-21 1996-03-09 Forma sólida de medicamento

Country Status (16)

Country Link
US (1) US5945127A (pt)
EP (1) EP0814781B1 (pt)
JP (1) JPH11502208A (pt)
AT (1) ATE213153T1 (pt)
AU (1) AU5105196A (pt)
BR (1) BR9607796A (pt)
CA (1) CA2213720A1 (pt)
DE (2) DE19509806A1 (pt)
DK (1) DK0814781T3 (pt)
ES (1) ES2172655T3 (pt)
HU (1) HUP9801151A3 (pt)
IL (1) IL117530A (pt)
NO (1) NO974337L (pt)
PT (1) PT814781E (pt)
WO (1) WO1996029060A1 (pt)
ZA (1) ZA962242B (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19602206A1 (de) * 1996-01-23 1997-07-24 Basf Ag Zubereitungen nichtsteroidaler Analgetika
DE19710009A1 (de) * 1997-03-12 1998-09-24 Knoll Ag Mehrphasige wirkstoffhaltige Zubereitungsformen
CA2214895C (en) * 1997-09-19 1999-04-20 Bernard Charles Sherman Improved pharmaceutical composition comprising fenofibrate
JPH11137208A (ja) * 1997-11-14 1999-05-25 Nikken Chem Co Ltd 口腔内速溶性固形物及びその製造方法
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
EP1027886B1 (en) * 1999-02-10 2008-07-09 Pfizer Products Inc. Pharmaceutical solid dispersions
CA2359945C (en) * 1999-11-12 2011-04-26 Abbott Laboratories Inhibitors of crystallization in a solid dispersion
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
CA2438641A1 (en) * 2001-02-15 2002-08-22 King Pharmaceuticals, Inc. Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US20030224047A1 (en) * 2001-02-15 2003-12-04 Franz G. Andrew Levothyroxine compositions and methods
US20030032675A1 (en) * 2001-02-15 2003-02-13 Franz G. Andrew Manufacture of thyroid hormone tablets having consistent active moiety amounts
US20030180353A1 (en) * 2001-08-10 2003-09-25 Franz G. Andrew Stabilized pharmaceutical compositions
US20030190349A1 (en) * 2001-08-10 2003-10-09 Franz G. Andrew Methods of stabilizing pharmaceutical compositions
US20030198671A1 (en) * 2001-08-10 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique plasma AUC properties
US20030198667A1 (en) * 2001-08-10 2003-10-23 Franz Andrew G. Methods of producing dispersible pharmaceutical compositions
US20030198672A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique triidothyronine plasma AUC properties
US20030199587A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique Cmax properties
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US20030195253A1 (en) * 2001-08-14 2003-10-16 Franz G. Andrew Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
US20030199586A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Unique levothyroxine aqueous materials
US20030203967A1 (en) * 2001-08-14 2003-10-30 Franz G. Andrew Levothyroxine compositions having unique Tmax properties
JPWO2003034302A1 (ja) * 2001-10-15 2005-02-03 株式会社シュタルク コンテンツ配信用サーバ及びこれを備えたコンテンツ配信システム
US20030191185A1 (en) * 2001-10-29 2003-10-09 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Tmax properties
BR0313428A (pt) * 2002-08-12 2005-06-28 Pfizer Prod Inc Composições farmacêuticas de drogas semi-ordenados e polìmeros
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US20100112088A1 (en) * 2003-08-29 2010-05-06 Jay Pravda Materials and methods for treatment of disorders associated with oxidative stress
US8916546B2 (en) 2003-08-29 2014-12-23 Therapeutic Research Llc Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
GB0403098D0 (en) * 2004-02-12 2004-03-17 Euro Celtique Sa Extrusion
AU2006244214A1 (en) * 2005-05-10 2006-11-16 Novartis Ag Modified release famciclovir pharmaceutical compositions
AU2011224098B2 (en) * 2005-05-10 2013-10-31 Novartis Ag Extrusion process for making compositions with poorly compressible therapeutic compounds
JP5400377B2 (ja) * 2005-05-10 2014-01-29 ノバルティス アーゲー 圧縮性に乏しい治療用化合物を有する組成物の製造法
US9109068B2 (en) 2005-07-21 2015-08-18 Akzo Nobel N.V. Hybrid copolymer compositions
US7666963B2 (en) * 2005-07-21 2010-02-23 Akzo Nobel N.V. Hybrid copolymers
US8674021B2 (en) 2006-07-21 2014-03-18 Akzo Nobel N.V. Sulfonated graft copolymers
US20080020961A1 (en) * 2006-07-21 2008-01-24 Rodrigues Klin A Low Molecular Weight Graft Copolymers
US20080181948A1 (en) * 2006-11-15 2008-07-31 Abbott Laboratories Solid pharmaceutical dosage formulations
JP2010529197A (ja) * 2007-06-13 2010-08-26 ジェイ プラーヴダ, 酸化的ストレス関連疾患の治療および診断のための材料および方法
US8613834B2 (en) 2008-04-03 2013-12-24 Basf Se Paper coating or binding formulations and methods of making and using same
US8636918B2 (en) 2011-08-05 2014-01-28 Ecolab Usa Inc. Cleaning composition containing a polysaccharide hybrid polymer composition and methods of controlling hard water scale
US8679366B2 (en) 2011-08-05 2014-03-25 Ecolab Usa Inc. Cleaning composition containing a polysaccharide graft polymer composition and methods of controlling hard water scale
US8853144B2 (en) 2011-08-05 2014-10-07 Ecolab Usa Inc. Cleaning composition containing a polysaccharide graft polymer composition and methods of improving drainage
US8841246B2 (en) 2011-08-05 2014-09-23 Ecolab Usa Inc. Cleaning composition containing a polysaccharide hybrid polymer composition and methods of improving drainage
EP2773321B1 (en) 2011-11-04 2015-09-09 Akzo Nobel Chemicals International B.V. Graft dendrite copolymers, and methods for producing the same
WO2013064647A1 (en) 2011-11-04 2013-05-10 Akzo Nobel Chemicals International B.V. Hybrid dendrite copolymers, compositions thereof and methods for producing the same
US9687010B2 (en) * 2012-03-14 2017-06-27 Mccormick & Company, Incorporated Extrusion encapsulation of actives at an increased load, using surface active plant extracts
US8945314B2 (en) 2012-07-30 2015-02-03 Ecolab Usa Inc. Biodegradable stability binding agent for a solid detergent
JP6423353B2 (ja) 2012-11-09 2018-11-14 ハズ トゥー,エルエルシー 潰瘍性大腸炎の治療のための長期安定性を有する浣腸剤組成物
US9365805B2 (en) 2014-05-15 2016-06-14 Ecolab Usa Inc. Bio-based pot and pan pre-soak

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4520180A (en) * 1982-09-20 1985-05-28 Gaf Corporation Polymerization of vinylpyrrolidone to various molecular weights using a single initiator system consisting essentially of t-Butylperoxypivalate
US4712460A (en) * 1985-11-18 1987-12-15 Biotrack, Inc. Integrated drug dosage form and metering system
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen

Also Published As

Publication number Publication date
DK0814781T3 (da) 2002-03-18
CA2213720A1 (en) 1996-09-26
US5945127A (en) 1999-08-31
HUP9801151A3 (en) 2000-06-28
WO1996029060A1 (de) 1996-09-26
EP0814781A1 (de) 1998-01-07
AU5105196A (en) 1996-10-08
IL117530A0 (en) 1996-07-23
HUP9801151A2 (hu) 1998-08-28
PT814781E (pt) 2002-07-31
DE19509806A1 (de) 1996-09-26
JPH11502208A (ja) 1999-02-23
NO974337D0 (no) 1997-09-19
NO974337L (no) 1997-09-19
ES2172655T3 (es) 2002-10-01
EP0814781B1 (de) 2002-02-13
ATE213153T1 (de) 2002-02-15
IL117530A (en) 1999-12-31
ZA962242B (en) 1997-09-22
DE59608732D1 (de) 2002-03-21

Similar Documents

Publication Publication Date Title
BR9607796A (pt) Forma sólida de medicamento
PT809488E (pt) Preparacoes solidas de substancias activas****************
BG102313A (en) Method for the preparation of multilayer solid medicamentous forms for oral or rectal administration
DK0706378T3 (da) Ny farmaceutisk formulering.
ATE293458T1 (de) Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
IL124674A0 (en) Piperazine derivatives pharmaceutical compositions containing the same and use thereof
DE69619832D1 (de) Schmerzlindernde arzneistoffzusammensetzung
DE69713287D1 (de) Verbindungen von wirkstoffen, welche klopidogrel und antithrombotische mittel enthalten
FI970934A0 (fi) Implantoitava valukappale vaikuttavien aineiden annostelemiseksi kasveihin
HUP9802423A2 (hu) Hiperproliferatív megbetegedések kombinált gyógyászati kezelése
NO980296D0 (no) Forbedrede terapeutiske midler
GEP20063719B (en) Prevention of Migraine Recurrence
ATE255895T1 (de) Zusammensetzungzur verminderung von schmerzen, die ein nicht narkotischen analgetika und ein analgetikabekräftiger enthält
FR2735132B1 (fr) Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant
ATE173399T1 (de) Retardtablette mit einem gehalt an diclofenac-na
RS49520B (sr) Antimikrobno aktivne smeše
FR2705895B1 (fr) Comprimés médicamenteux exempts d'agent lubrifiant.
NO984651D0 (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
ES2112978T3 (es) Composicion de polimeros para aplicaciones medicas.
ATE206911T1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
EP0480391A3 (en) Emulsion-free emulsion polymers, their production and their use in sustained-release pharmaceutical compositions
FR2677250B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
IT1296613B1 (it) Farmaco per la cura dell'ircismo contenente un adrenocorticosteroide.
TR199800904T2 (xx) Yeni kinoksalindiyon t�revleri'nin �retimi ve ila�larda kullan�m�
FR2702960B1 (fr) Leurre pour l'administration orale de médicaments vétérinaires.

Legal Events

Date Code Title Description
FA Application withdrawn